IP Library Granted Patent US 8,916,211
Granted Patent B2
US 8,916,211 · App. 13/900,235 · Granted Dec 23, 2014

Method and composition for preventing and treating avian influenza in poultry

Inventors: Charles Hensley (Cypress, CA); Sung Pyo (Irvine, CA)
Assignee: Abattis Bioceuticals Corp.
A61K31/352A61K45/06A61K31/353A61K36/82
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,916,211
App. No.
13/900,235
Granted
Dec 23, 2014
Kind
B2
Abstract

A method and composition for preventing and treating avian influenza utilizes an effective quantity of polyphenolic(s) and its derivatives in combination with a carrier. The anti-avian influenza ingredient having a composition selected from the group consisting of theaflavin, theaflavin-3,3′-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3′-gallate, thearubigin, gallic acid, tannic acid, (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (+)-epicatechin (EC), (−)-gallocatechin gallate (GCG), and catechin.

Claims (18)

1. A method for treating and reducing the risk of avian influenza in a poultry, comprising a step of administering to said poultry an effective amount of a composition comprising an anti-avian influenza ingredient containing a polyphenolic selected from the group consisting of theaflavin, theaflavin-3,3′-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3′-gallate, thearubigin, gallic acid, tannic acid, (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (+)-epicatechin (EC), (−)-gallocatechin gallate (GCG), catechin, and combinations thereof, wherein the composition is administered directly to poultry by inhalation.

2. The method of claim 1 , wherein the composition comprises the anti-avian influenza ingredient in combination with a carrier.

3. The method of claim 2 , wherein the composition comprises 98.0% by weight of the carrier and 2.0% by weight of the anti-avian influenza ingredient.

4. The method of claim 1 , wherein the polyphenolic is extracted from tea leaves.

5. The method of claim 3 , wherein the polyphenolic is extracted from tea leaves.

6. The method of claim 1 , wherein theaflavin, theaflavin-3,3′-digallate, theaflavin-3 gallate, thearubigin, gallic acid, and tannic acid are extracted from black tea.

7. The method of claim 3 , wherein theaflavin, theaflavin-3,3′-digallate, theaflavin-3 gallate, thearubigin, gallic acid, and tannic acid are extracted from black tea.

8. The method of claim 1 , wherein (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (−)epicatechin gallate (ECG), (+)-epicatechin (EC), (−)gallocatechin gallate (GCG), and catechin are extracted from green tea.

9. The method of claim 3 , wherein (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (−)epicatechin gallate (ECG), (+)-epicatechin (EC), (−)gallocatechin gallate (GCG), and catechin are extracted from green tea.

10. A method for treating and reducing the risk of avian influenza in a poultry, comprising a step of administering to said poultry an effective amount of a composition comprising an anti-avian influenza ingredient containing a polyphenolic selected from the group consisting of theaflavin, theaflavin-3,3′-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3′-gallate, thearubigin, gallic acid, tannic acid, (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (+)-epicatechin (EC), (−)-gallocatechin gallate (GCG), catechin, and combinations thereof, wherein the composition is administered directly to poultry by injection.

11. The method of claim n, wherein the composition comprises the anti-avian influenza ingredient in combination with a carrier.

12. The method of claim 11 , wherein the composition comprises 98.0% by weight of the carrier and 2.0% by weight of the anti-avian influenza ingredient.

13. The method of claim 10 , wherein the polyphenolic is extracted from tea leaves.

14. The method of claim 12 , wherein the polyphenolic is extracted from tea leaves.

15. The method of claim 10 , wherein theaflavin, theaflavin-3,3′-digallate, theaflavin-3 gallate, thearubigin, gallic acid, and tannic acid are extracted from black tea.

16. The method of claim 12 , wherein theaflavin, theaflavin-3,3′-digallate, theaflavin-3 gallate, thearubigin, gallic acid, and tannic acid are extracted from black tea.

17. The method of claim 10 , wherein (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (−)epicatechin gallate (ECG), (+)-epicatechin (EC), (−)gallocatechin gallate (GCG), and catechin are extracted from green tea.

18. The method of claim 12 , wherein (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (−)epicatechin gallate (ECG), (+)-epicatechin (EC), (−)gallocatechin gallate (GCG), and catechin are extracted from green tea.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2017
From: WITHROW, MICHAEL
To: AREV NUTRITION SCIENCES INC.
Reel/Frame 042773/0654 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2015
From: ABATTIS BIOCEUTICALS CORP.
To: WITHROW, MICHAEL
Reel/Frame 036457/0805 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2013
From: HENSLEY, CHARLES
To: SICAN VENTURES INC.
Reel/Frame 030727/0678 →
CHANGE OF NAME Recorded Jul 2, 2013
From: ABATTIS BIOLOGIX CORPORATION
To: ABATTIS BIOCEUTICALS CORP.
Reel/Frame 030727/0871 →
CHANGE OF NAME Recorded Jul 1, 2013
From: SICAN VENTURES INC.
To: ABATTIS BIOLOGIX CORPORATION
Reel/Frame 030722/0420 →
Continuity (3)
Continuation 11903517 · Sep 20, 2007
Provisional Application 60846311 · Sep 20, 2006
Related Publication 20130253047A1 · Sep 26, 2013